bioecon Member area

Market access & commercial

A product claim is admissible exactly as far as the substance is definable and the effect measurable; panels are instruments built out of people.

7 pages
Explanatory reference: why a technology works and where the science is unsettled. Drafted with AI assistance; pages carry no per-claim references and have not yet been reviewed by a subject expert — use them for orientation, not as a citable source. The evidence for each technology, with graded sources, is in its dossier. How this reference is made →

The cluster is about what stands between a product and its label claim. A trained sensory panel is an instrument assembled from people, with its own calibration and drift. A health claim is substantiable only if the substance can be defined, the effect measured, and the link between them demonstrated — that is how EFSA is built. Substance identity under REACH decides whether a fermentation-derived product inherits another molecule’s registration data. Feed-additive authorisation stands on two study designs. Focus groups and A/B tests measure what people say about buying, not what they buy — and the honest page keeps the two apart.

Start with health claim substantiation: the triad of definable substance, measurable effect and demonstrated link sets the rules for the whole cluster.

Articles 7

Consumer concept and A/B testing
Asking people what they would buy measures something other than what they buy, and the gap is widest exactly where bio-based products make their claims.
Feed additive authorisation
Whether a feed additive is permitted turns on two study designs — a tolerance trial in the animal that eats it, and an efficacy trial that has to detect a small zootechnical effect.
Health claim substantiation
A claim is substantiable only if the substance can be defined, the effect is a measurable physiological benefit, and a human study links the two.
Pre-approval access to investigational medicines
Giving an unapproved drug to a patient outside a trial is an evidentiary decision as much as a clinical one: it produces data that cannot be interpreted, from doses that could have been randomised.
Substance identity under REACH
A fermentation-derived chemical can inherit the registration data of its petrochemical twin only if it is the same substance, and sameness is decided on the impurity profile.
Sensory evaluation panels
A trained panel is an instrument built out of people — and like any instrument it has to be calibrated, and it drifts.
Biomass certification and chain of custody
Segregation, mass balance and book-and-claim are three different promises, and only one of them is about the material in front of you.